Bronwyn A. Kingwell

Bio21 30 Flemington Rd
Parkville, VIC 3010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Evaluation of Topical Reconstituted HDL as a Treatment for Diabetic Wounds in Murine and Porcine Models.

Evaluation of Topical Reconstituted HDL as a Treatment for Diabetic Wounds in Murine and Porcine Models.

Journal: Biomolecules

Published: May 12, 2026

Interrupting prolonged sitting reduces postprandial GIP but not GLP-1 responses in type 2 diabetes.

Interrupting prolonged sitting reduces postprandial GIP but not GLP-1 responses in type 2 diabetes.

Journal: Diabetes, obesity & metabolism

Published: June 18, 2025

Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.

Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.

Journal: JACC. Advances

Published: December 16, 2024

Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.

Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.

Journal: Circulation

Published: November 04, 2024

Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport.

Apolipoprotein A1 (CSL112) Increases Lecithin-Cholesterol Acyltransferase Levels in HDL Particles and Promotes Reverse Cholesterol Transport.

Journal: JACC. Basic to translational science

Published: September 26, 2024

Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease.

Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease.

Journal: PloS one

Published: August 21, 2024

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial.

Journal: European heart journal

Published: July 22, 2024

CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction.

CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction.

Journal: Journal of the American Heart Association

Published: May 03, 2024

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.

Journal: Journal of the American College of Cardiology

Published: March 12, 2024

Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant.

Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 21, 2023

CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.

CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 30, 2023

Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors.

Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors.

Journal: Scientific reports

Published: December 01, 2022

Showing 1-12 of 132

Last Updated: 09/26/2026